Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Liabilities and Shareholders Equity (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $61.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.56% to $61.7 million in Q4 2025 year-over-year; TTM through Nov 2025 was $253.7 million, a 0.73% increase, with the full-year FY2025 number at $61.7 million, down 4.56% from a year prior.
  • Liabilities and Shareholders Equity was $61.7 million for Q4 2025 at Cryo Cell International, down from $63.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $105.3 million in Q1 2021 to a low of $250591.0 in Q2 2021.
  • A 5-year average of $62.1 million and a median of $63.8 million in 2025 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: tumbled 99.44% in 2021, then skyrocketed 22005.72% in 2022.
  • Cryo Cell International's Liabilities and Shareholders Equity stood at $60.7 million in 2021, then increased by 6.97% to $64.9 million in 2022, then dropped by 0.32% to $64.7 million in 2023, then changed by 0.0% to $64.7 million in 2024, then fell by 4.56% to $61.7 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Liabilities and Shareholders Equity are $61.7 million (Q4 2025), $63.2 million (Q3 2025), and $64.4 million (Q2 2025).